Christina J. Gutowski, MD, MPH, is an attending orthopaedic oncologist at Cooper University Health Care. She joined the Cooper Department of Orthopaedic Surgery after completing her surgical fellowship at Memorial Sloan-Kettering Cancer Center in New York, NY.

She serves as one of the surgeons at the multidisciplinary Orthopaedic Oncology Center at Cooper, supported by MD Anderson Cancer Center at Cooper, as well as the Cooper Bone and Joint Institute. Her special interests and clinical focus include benign and malignant bone and soft tissue tumors, limb salvage and reconstruction, metastatic bone disease, and complex joint arthroplasty. She also holds a position on the academic staff of Cooper Medical School of Rowan University.

Dr. Gutowski received her medical degree from Rutgers-New Jersey Medical School in Newark, NJ, where she achieved AOA status. She achieved a Masters in Public Health, with a focus in Health Policy and Management, from the University of California-Berkeley during her medical training. She then completed her surgical internship and orthopaedic surgery residency at Thomas Jefferson University Hospital in Philadelphia, PA. Dr. Gutowski completed a clinical fellowship in orthopaedic oncology at Memorial Sloan-Kettering Cancer Center prior to joining the staff at Cooper. 

She is a board member of the Philadelphia Orthopaedic Society, and a Diplomate of the American Board of Orthopaedic Surgery. She is also an active member of the American Orthopaedic Association, Musculoskeletal Tumor Society, Ruth Jackson Orthopaedic Society, New Jersey Orthopaedic Society, and Eastern Orthopaedic Association.​

Kelsey Hall, MS, is a Medical Physicist at the MD Anderson Cancer Center at Cooper. She earned her MS from the University of Pennsylvania and completed residency at Cooper University Hospital in 2023.

Katie Haroldson, MD, MPH, is an Assistant Professor of Medicine at Cooper Medical School of Rowan University (CMSRU) and Assistant Program Director for the Internal Medicine Residency.​ She graduated from Boston College and went on to receive her MD and MPH from Tulane University School of Medicine in New Orleans, LA, and was inducted into the Gold Humanism Society. She completed her internship and residency in internal medicine at the University of North Carolina in Chapel Hill, NC. During her training, she developed a special interest in bedside rounding and teaching; she received the ACGME Back to Bedside Grant during its inaugural year.

Dr. Haroldson currently serves as an academic Hospitalist at Cooper University Hospital and at Inspira Vineland Hospital. She is involved in both resident and medical student education. She is the Course Director for the Physical Diagnosis Course for second year medical students at CMSRU and the director of the Hospitalist Track for Internal Medicine residents. 

Rachel Haroz, MD, FAACT, is Medical Director of the Cooper University Health Care Center for Healing, Division Head of Toxicology and Addiction Medicine at Cooper University Health Care, and Associate Professor of Emergency Medicine (EM) at Cooper Medical School of Rowan University (CMSRU). She is triple-board certified in EM, medical toxicology, and addiction medicine, obtaining her bachelor of arts degree in biology from Brandeis University and medical degree from Tufts University, and completing a residency in EM and fellowship in medical toxicology.

She has spent nearly her entire career thus far working in inner city emergency departments (ED), mostly in the Camden, New Jersey area where opioid intoxication, abuse, and dependency are rampant. She helped build and now staffs the Center for Healing in Camden, an addiction medicine specialty clinic dedicated to treating patients with SUD. Further she helped build an integrated clinic for patients with HIV and SUD.

In 2016, Dr. Haroz helped create and implement an initiative to prescribe buprenorphine from the ED and "bridge" patients to treatment to various community partners (now known as CUH EDAP, Cooper University Health Care Emergency Department Addiction Pathways). In 2019, she helped launch an innovative program aimed at initiating buprenorphine via paramedics in the field (now known as Bupe FIRST EMS, Buprenorphine Field Initiation of ReScue Treatment). She is also heavily involved in the education of residents, medical students, and pharmacists, and organizes education forums focused on topics related to opioid dependency and treatment.

Follow Dr. Haroz on Twitter.